Levosimendan Injection

[Indications]
It is suitable for the short-term treatment of acute decompensated heart failure in patients with reduced cardiac contractility who require increased cardiac output support.

[Usage and dosage]
This product is administered by intravenous infusion. The recommended loading dose is 6–12 μg/kg infused over 10 minutes, followed by a continuous infusion of 0.1 μg/kg/min. The infusion rate may be adjusted according to the patient's response, usually within the range of 0.05–0.2 μg/kg/min. The recommended treatment duration is generally 24 hours. Blood pressure, heart rate, and clinical response should be monitored during administration.